Abstract:Objectives: To explore whether asymptomatic inflammatory prostatitis is associated with prostatic enlargement beyond that of benign prostatic hyperplasia patients without asymptomatic inflammatory prostatitis, and whether asymptomatic inflammatory prostatitis affects long-term outcomes of transurethral resection of the prostate. Methods: The present study involved 106 benign prostatic hyperplasia patients who underwent transurethral resection of the prostate. Clinical and pathological parameters were compared between those with benign prostatic hyperplasia associated with asymptomatic inflammatory prostatitis and those with benign prostatic hyperplasia alone. Results: A total of 55 patients (52%) were found to have benign prostatic hyperplasia and asymptomatic inflammatory prostatitis, whereas 51 patients (48%) had benign prostatic hyperplasia alone. The prostate volume of the benign prostatic hyperplasia/asymptomatic inflammatory prostatitis group was significantly larger than the benign prostatic hyperplasia alone group: 68.1 cm(3) (interquartile range 45.7-86.3) versus 44.1 cm(3) (interquartile range 30.9-72.1), P = 0.036. In terms of histopathological analysis, benign prostatic hyperplasia/asymptomatic inflammatory prostatitis patients were more likely to show mild (53%), focal (67%) and stromal (40%) prostatic inflammation in our study. Furthermore, statistically significant differences of International Prostate Symptom Score were found 3 years after transurethral resection of the prostate, with benign prostatic hyperplasia/asymptomatic inflammatory prostatitis patients reporting higher (worse) scores than benign prostatic hyperplasia alone patients (P = 0.025). Conclusions: Chronic prostatic inflammatory process might progressively conduce to benign prostatic hyperplasia development, which can also result in prostate enlargement and worsen long-term postoperative International Prostate Symptom Scores. Multicenter studies with larger cohorts and longer follow-up periods are required to confirm these findings.

Regulation of CCN1 on angiogenesis in benign prostatic hyperplasia

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

[Impact of Hypertension on Angiogenesis in the Tissues of Benign Prostatic Hyperplasia].

Correlation Between Molecular Biomarkers and Risk Factors for the Clinical Progression of Benign Prostatic Hyperplasia Using Tissue Micro Array Immuno Staining

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

Expression of Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor in Benign Prostatic Hyperplasia

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate

Increased expressions of VEGF and VEGF-C in prostate cancer tissue are associated with tumor progression

The Endothelial Function Study of Benign Prostatic Hyperplasia

Associated study on expression of androgen receptor and type Ⅰ transforming growth factor- β receptor in BPH

1448: Role of Angiogenesis and Angiogenic Factor CCN1 in Symptomatic and Asymptomatic Benign Prostatic Hyperplasia

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

YY1-miR-146a-YY1 Regulatory Circuitry: A Potential Mechanism of Prostate Cancer Formation and Progression

Distribution and expression of angiotensin Ⅱ and angiotensin Ⅱ receptor AT1 in benign prostatic hyperplasia with and without concomitant hypertension

Association study of SIRT1 expression with benign prostatic hyperplasia

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

BLCA1 Expression is Associated with Angiogenesis of Bladder Cancer and is Correlated with Common Pro-Angiogenic Factors

Role of Inflammation in Benign Prostatic Hyperplasia Development among Han Chinese: A Population‐based and Single‐institutional Analysis

Effect of Hypertension on Cell Proliferation and Apoptosis in Benign Prostatic Hyperplasia

Identification Of Key Genes And Pathways In Benign Prostatic Hyperplasia

High-level Expression of Periostin is Significantly Correlated with Tumor Angiogenesis in Prostate Cancer.